Generation Bio Co. (GBIO) Tops Q3 EPS by 4c

Generation Bio Co. (NASDAQ: GBIO) reported Q3 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $7.55 million versus the consensus estimate of $1.97 million.

For earnings history and earnings-related data on Generation Bio Co. (GBIO) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Piper Sandler Reiterates Overweight Rating on Madrigal Pharmaceuticals (MDGL)
• RBC Capital on argenx SE (ARGX): 'We Are Buyers On Myositis Stock Weakness'